Reneo Other Liab from 2010 to 2024

RPHM Stock  USD 1.66  0.06  3.49%   
Reneo Pharmaceuticals Other Liabilities yearly trend continues to be very stable with very little volatility. Other Liabilities is likely to drop to about 31.7 K. During the period from 2010 to 2024, Reneo Pharmaceuticals Other Liabilities quarterly data regression pattern had sample variance of 21.9 B and median of  41,000. View All Fundamentals
 
Other Liabilities  
First Reported
2010-12-31
Previous Quarter
33.4 K
Current Value
31.7 K
Quarterly Volatility
147.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Reneo Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reneo main balance sheet or income statement drivers, such as Net Interest Income of 24.8 K, Interest Income of 24.8 K or Depreciation And Amortization of 551.2 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.58. Reneo financial statements analysis is a perfect complement when working with Reneo Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Reneo Pharmaceuticals Technical models . Check out the analysis of Reneo Pharmaceuticals Correlation against competitors.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.

Latest Reneo Pharmaceuticals' Other Liab Growth Pattern

Below is the plot of the Other Liab of Reneo Pharmaceuticals over the last few years. It is Reneo Pharmaceuticals' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reneo Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Pretty Stable
   Other Liab   
       Timeline  

Reneo Other Liab Regression Statistics

Arithmetic Mean76,736
Geometric Mean46,107
Coefficient Of Variation192.68
Mean Deviation71,235
Median41,000
Standard Deviation147,856
Sample Variance21.9B
Range582K
R-Value0.23
Mean Square Error22.3B
R-Squared0.05
Significance0.42
Slope7,478
Total Sum of Squares306.1B

Reneo Other Liab History

202431.7 K
202333.4 K
202229 K
2021611 K
202036 K

About Reneo Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Reneo Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Reneo Pharmaceuticals investors use historical funamental indicators, such as Reneo Pharmaceuticals's Other Liab, to determine how well the company is positioned to perform in the future. Although Reneo Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Reneo Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Reneo Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Reneo Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Reneo Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities33.4 K31.7 K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Reneo Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Reneo Pharmaceuticals is a strong investment it is important to analyze Reneo Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reneo Pharmaceuticals' future performance. For an informed investment choice regarding Reneo Stock, refer to the following important reports:
Check out the analysis of Reneo Pharmaceuticals Correlation against competitors.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Reneo Stock analysis

When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.17)
Return On Assets
(0.52)
Return On Equity
(0.84)
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.